As a result, the present study was undertaken to investigate IGF1R expression from genetic (BRCA1 mutation) and epigenetic (BRCA1 promoter methylation) aspects in ovarian cancer and to provide novel insights into the regulatory mechanism involving IGF1R. The gene discussed is BRCA1; the disease is ovarian carcinoma.